New Alzheimer's drug 8M2D enters first human safety trials
Disease control
Not yet recruiting
This early-stage study tests a new drug called 8M2D for the first time in people. The goal is to see if it is safe and tolerable in healthy adults and in people with early Alzheimer's disease. Researchers will also check if 8M2D can lower amyloid beta, a protein linked to Alzheim…
Phase: PHASE1 • Sponsor: Cenna Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC